Positive regulation of type 2 immune response

pathway activity — cross-omics
GO:0002830Cross-omicsSHRNA → SHRNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Positive regulation of type 2 immune response pathway is significantly associated with the shRNA dependency of multiple genes, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are XCL1, GATA3, and ARSJ, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, XCL1 grouped by Positive regulation of type 2 immune response-low versus -high activity in BLOOD_Leukemia.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaXCL1 →-0.306-1.273.001<.00139
BREASTGATA3 →-0.481-1.244<.001<.00136
PANCREASARSJ →-0.215-1.346.008.00235
LUNG_SCLCPHF5A →-0.546-1.295.001.00234
BLOOD_MyelomaATR →+0.477+1.394.001.00934
CNSHOXB6 →-0.247-1.406.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

XCL1 by Positive regulation of type 2 immune response activity — BLOOD_Leukemia

Box plot of XCL1 in Positive regulation of type 2 immune response-low vs -high samples in BLOOD_Leukemia.

Explore this box plot interactively →

Exploration